These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 34228254)
41. Antibiotic Use in China's Public Healthcare Institutions During the COVID-19 Pandemic: An Analysis of Nationwide Procurement Data, 2018-2020. Yang Y; Geng X; Liu X; Wen X; Wu R; Cui D; Mao Z Front Pharmacol; 2022; 13():813213. PubMed ID: 35237164 [No Abstract] [Full Text] [Related]
42. SARS-CoV-2 Wave Two Surveillance in East Asia and the Pacific: Longitudinal Trend Analysis. Post LA; Lin JS; Moss CB; Murphy RL; Ison MG; Achenbach CJ; Resnick D; Singh LN; White J; Boctor MJ; Welch SB; Oehmke JF J Med Internet Res; 2021 Feb; 23(2):e25454. PubMed ID: 33464207 [TBL] [Abstract][Full Text] [Related]
43. Evaluation of China's Hubei control strategy for COVID-19 epidemic: an observational study. Liu Y; Zheng F; Du Z; Li J; Gu J; Jiang M; Yoneoka D; Gilmour S; Hao Y BMC Infect Dis; 2021 Aug; 21(1):820. PubMed ID: 34399697 [TBL] [Abstract][Full Text] [Related]
44. Prevention and control mechanism for coronavirus disease 2019 epidemic at the primary level: perspective from China. Zhang X; Wang Y Epidemiol Infect; 2020 Jul; 148():e161. PubMed ID: 32713366 [TBL] [Abstract][Full Text] [Related]
45. Should we remain hopeful? The key 8 weeks: spatiotemporal epidemic characteristics of COVID-19 in Sichuan Province and its comparative analysis with other provinces in China and global epidemic trends. Xu X; Zeng J; Liu R; Liu Y; Zhou X; Zhou L; Dong T; Cha Y; Wang Z; Deng Y; Zhang Y; Feng L; Pu C; Wu X; Zhong B BMC Infect Dis; 2020 Nov; 20(1):807. PubMed ID: 33153445 [TBL] [Abstract][Full Text] [Related]
46. How Did Chinese Government Implement Unconventional Measures Against COVID-19 Pneumonia. Yu X; Li N Risk Manag Healthc Policy; 2020; 13():491-499. PubMed ID: 32581611 [TBL] [Abstract][Full Text] [Related]
47. A rapid mixed-methods evaluation of remote home monitoring models during the COVID-19 pandemic in England. Fulop NJ; Walton H; Crellin N; Georghiou T; Herlitz L; Litchfield I; Massou E; Sherlaw-Johnson C; Sidhu M; Tomini SM; Vindrola-Padros C; Ellins J; Morris S; Ng PL Health Soc Care Deliv Res; 2023 Jul; 11(13):1-151. PubMed ID: 37800997 [TBL] [Abstract][Full Text] [Related]
48. Corona Virus (COVID-19) "Infodemic" and Emerging Issues through a Data Lens: The Case of China. Hua J; Shaw R Int J Environ Res Public Health; 2020 Mar; 17(7):. PubMed ID: 32235433 [TBL] [Abstract][Full Text] [Related]
49. Phase-adjusted estimation of the number of Coronavirus Disease 2019 cases in Wuhan, China. Wang H; Wang Z; Dong Y; Chang R; Xu C; Yu X; Zhang S; Tsamlag L; Shang M; Huang J; Wang Y; Xu G; Shen T; Zhang X; Cai Y Cell Discov; 2020; 6():10. PubMed ID: 32133152 [TBL] [Abstract][Full Text] [Related]
50. Development, Status Quo, and Challenges to China's Health Informatization During COVID-19: Evaluation and Recommendations. Huang M; Wang J; Nicholas S; Maitland E; Guo Z J Med Internet Res; 2021 Jun; 23(6):e27345. PubMed ID: 34061761 [TBL] [Abstract][Full Text] [Related]
51. Transmission patterns of COVID-19 in the mainland of China and the efficacy of different control strategies: a data- and model-driven study. Zu J; Li ML; Li ZF; Shen MW; Xiao YN; Ji FP Infect Dis Poverty; 2020 Jul; 9(1):83. PubMed ID: 32631426 [TBL] [Abstract][Full Text] [Related]
52. Transmission dynamics and control of two epidemic waves of SARS-CoV-2 in South Korea. Ryu S; Ali ST; Noh E; Kim D; Lau EHY; Cowling BJ BMC Infect Dis; 2021 May; 21(1):485. PubMed ID: 34039296 [TBL] [Abstract][Full Text] [Related]
53. Could masks curtail the post-lockdown resurgence of COVID-19 in the US? Ngonghala CN; Iboi EA; Gumel AB Math Biosci; 2020 Nov; 329():108452. PubMed ID: 32818515 [TBL] [Abstract][Full Text] [Related]
54. Fear of panoptic surveillance: using digital technology to control the COVID-19 epidemic. Keshet Y Isr J Health Policy Res; 2020 Nov; 9(1):67. PubMed ID: 33239094 [TBL] [Abstract][Full Text] [Related]
55. Association of Public Health Interventions With the Epidemiology of the COVID-19 Outbreak in Wuhan, China. Pan A; Liu L; Wang C; Guo H; Hao X; Wang Q; Huang J; He N; Yu H; Lin X; Wei S; Wu T JAMA; 2020 May; 323(19):1915-1923. PubMed ID: 32275295 [TBL] [Abstract][Full Text] [Related]
56. Digital Contact Tracing Based on a Graph Database Algorithm for Emergency Management During the COVID-19 Epidemic: Case Study. Mao Z; Yao H; Zou Q; Zhang W; Dong Y JMIR Mhealth Uhealth; 2021 Jan; 9(1):e26836. PubMed ID: 33460389 [TBL] [Abstract][Full Text] [Related]
57. Impact of Systematic Factors on the Outbreak Outcomes of the Novel COVID-19 Disease in China: Factor Analysis Study. Cao Z; Tang F; Chen C; Zhang C; Guo Y; Lin R; Huang Z; Teng Y; Xie T; Xu Y; Song Y; Wu F; Dong P; Luo G; Jiang Y; Zou H; Chen YQ; Sun L; Shu Y; Du X J Med Internet Res; 2020 Nov; 22(11):e23853. PubMed ID: 33098287 [TBL] [Abstract][Full Text] [Related]
58. The public health response to the COVID-19 outbreak in mainland China: a narrative review. Zanin M; Xiao C; Liang T; Ling S; Zhao F; Huang Z; Lin F; Lin X; Jiang Z; Wong SS J Thorac Dis; 2020 Aug; 12(8):4434-4449. PubMed ID: 32944357 [TBL] [Abstract][Full Text] [Related]
59. What Caused the Outbreak of COVID-19 in China: From the Perspective of Crisis Management. Shangguan Z; Wang MY; Sun W Int J Environ Res Public Health; 2020 May; 17(9):. PubMed ID: 32397199 [TBL] [Abstract][Full Text] [Related]
60. China's model to combat the COVID-19 epidemic: a public health emergency governance approach. Ning Y; Ren R; Nkengurutse G Glob Health Res Policy; 2020; 5():34. PubMed ID: 32685691 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]